Decision: Favourable

Study Title:

HORIZON: A PHASE II, OPEN-LABEL, OUTCOMES-ASSESSOR MASKED, MULTICENTRE, RANDOMISED, CONTROLLED STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TWO DOSES OF GT005 ADMINISTERED AS A SINGLE SUBRETINAL INJECTION IN SUBJECTS WITH GEOGRAPHIC ATROPHY SECONDARY TO D

  • NREC Code:

    21-NREC-CT-129

  • Decision:

    Favourable

  • Meeting Date:

    03/11/2021

  • Study Type:

    CT application

  • Principal Investigator:

    Dr Eugene Ng

  • PI Institution:

    Institute of Eye Surgery, UPMC Whitfield Hospital, Butlerstown, Waterford, X91 DH9W, Ireland

  • Sponsor:

    Gyroscope Therapeutics

Scroll to Top
Skip to content